China Medical System Holdings Ltd is active in the healthcare segment... Show more
CHSYF moved below its 50-day moving average on September 22, 2025 date and that indicates a change from an upward trend to a downward trend. In of 7 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The 10-day moving average for CHSYF crossed bearishly below the 50-day moving average on September 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for CHSYF entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.376) is normal, around the industry mean (16.996). P/E Ratio (14.057) is within average values for comparable stocks, (73.238). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.945). Dividend Yield (0.028) settles around the average of (0.030) among similar stocks. P/S Ratio (2.953) is also within normal values, averaging (45.893).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHSYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHSYF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.
Industry PharmaceuticalsGeneric
A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.
Ticker / NAME | Correlation To CHSYF | 1D Price Change % | ||
---|---|---|---|---|
CHSYF | 100% | N/A | ||
BSPK - CHSYF | 9% Poorly correlated | -6.90% | ||
CANN - CHSYF | 7% Poorly correlated | -2.68% | ||
CAIHF - CHSYF | 0% Poorly correlated | N/A | ||
CASBF - CHSYF | 0% Poorly correlated | N/A | ||
CANQF - CHSYF | -0% Poorly correlated | N/A | ||
More |
Ticker / NAME | Correlation To CHSYF | 1D Price Change % |
---|---|---|
CHSYF | 100% | N/A |
Pharmaceuticals: Generic industry (223 stocks) | -6% Poorly correlated | -1.84% |